vs
SuperCom Ltd(SPCB)与TriSalus Life Sciences, Inc.(TLSI)财务数据对比。点击上方公司名可切换其他公司
SuperCom Ltd的季度营收约是TriSalus Life Sciences, Inc.的1.1倍($14.2M vs $13.2M),SuperCom Ltd净利率更高(37.5% vs -73.9%,领先111.4%),TriSalus Life Sciences, Inc.同比增速更快(59.8% vs -1.5%),TriSalus Life Sciences, Inc.自由现金流更多($-2.5M vs $-3.6M)
Super.com是一家总部位于美国旧金山的科技公司,由侯赛因·法扎勒和施亨利联合创立。该公司主营金融服务业务,具体涵盖会员奖励计划以及旅行预订等相关服务,在出行与消费金融领域深耕发展。
TriSalus生命科学公司是一家临床阶段生物技术企业,专注于免疫肿瘤学与介入肿瘤学领域,研发专有的靶向给药技术,用于提升肝脏、胰腺等难治性实体瘤患者的治疗效果,主要在北美市场开展临床合作及业务运营。
SPCB vs TLSI — 直观对比
营收规模更大
SPCB
是对方的1.1倍
$13.2M
营收增速更快
TLSI
高出61.3%
-1.5%
净利率更高
SPCB
高出111.4%
-73.9%
自由现金流更多
TLSI
多$1.1M
$-3.6M
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $14.2M | $13.2M |
| 净利润 | $5.3M | $-9.8M |
| 毛利率 | 61.2% | 86.7% |
| 营业利润率 | 16.3% | -24.8% |
| 净利率 | 37.5% | -73.9% |
| 营收同比 | -1.5% | 59.8% |
| 净利润同比 | 79.5% | 3.5% |
| 每股收益(稀释后) | $1.32 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
SPCB
TLSI
| Q4 25 | — | $13.2M | ||
| Q3 25 | — | $11.6M | ||
| Q2 25 | $14.2M | $11.2M | ||
| Q1 25 | — | $9.2M | ||
| Q4 24 | — | $8.3M | ||
| Q3 24 | — | $7.3M | ||
| Q2 24 | $14.4M | $7.4M | ||
| Q1 24 | — | $6.5M |
净利润
SPCB
TLSI
| Q4 25 | — | $-9.8M | ||
| Q3 25 | — | $-10.8M | ||
| Q2 25 | $5.3M | $-8.3M | ||
| Q1 25 | — | $-10.4M | ||
| Q4 24 | — | $-10.1M | ||
| Q3 24 | — | $-2.4M | ||
| Q2 24 | $3.0M | $-4.3M | ||
| Q1 24 | — | $-13.2M |
毛利率
SPCB
TLSI
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | 61.2% | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | 52.3% | 87.6% | ||
| Q1 24 | — | 85.0% |
营业利润率
SPCB
TLSI
| Q4 25 | — | -24.8% | ||
| Q3 25 | — | -77.9% | ||
| Q2 25 | 16.3% | -65.4% | ||
| Q1 25 | — | -79.9% | ||
| Q4 24 | — | -91.8% | ||
| Q3 24 | — | -118.9% | ||
| Q2 24 | 7.7% | -111.0% | ||
| Q1 24 | — | -180.8% |
净利率
SPCB
TLSI
| Q4 25 | — | -73.9% | ||
| Q3 25 | — | -93.5% | ||
| Q2 25 | 37.5% | -73.9% | ||
| Q1 25 | — | -113.2% | ||
| Q4 24 | — | -122.4% | ||
| Q3 24 | — | -32.6% | ||
| Q2 24 | 20.6% | -58.8% | ||
| Q1 24 | — | -204.5% |
每股收益(稀释后)
SPCB
TLSI
| Q4 25 | — | $-0.22 | ||
| Q3 25 | — | $-0.96 | ||
| Q2 25 | $1.32 | $-0.27 | ||
| Q1 25 | — | $-0.39 | ||
| Q4 24 | — | $-0.38 | ||
| Q3 24 | — | $-0.12 | ||
| Q2 24 | $1.19 | $-0.21 | ||
| Q1 24 | — | $-0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $15.0M | $20.4M |
| 总债务越低越好 | $23.6M | — |
| 股东权益账面价值 | $37.3M | $-33.9M |
| 总资产 | $65.5M | $35.3M |
| 负债/权益比越低杠杆越低 | 0.63× | — |
8季度趋势,按日历期对齐
现金及短期投资
SPCB
TLSI
| Q4 25 | — | $20.4M | ||
| Q3 25 | — | $22.7M | ||
| Q2 25 | $15.0M | $26.5M | ||
| Q1 25 | — | $13.0M | ||
| Q4 24 | — | $8.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | $5.7M | $16.5M | ||
| Q1 24 | — | $4.0M |
总债务
SPCB
TLSI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $23.6M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $29.2M | — | ||
| Q1 24 | — | — |
股东权益
SPCB
TLSI
| Q4 25 | — | $-33.9M | ||
| Q3 25 | — | $-26.7M | ||
| Q2 25 | $37.3M | $-19.4M | ||
| Q1 25 | — | $-34.4M | ||
| Q4 24 | — | $-25.9M | ||
| Q3 24 | — | $-20.4M | ||
| Q2 24 | $13.8M | $-25.3M | ||
| Q1 24 | — | $-36.0M |
总资产
SPCB
TLSI
| Q4 25 | — | $35.3M | ||
| Q3 25 | — | $36.5M | ||
| Q2 25 | $65.5M | $41.3M | ||
| Q1 25 | — | $28.6M | ||
| Q4 24 | — | $24.0M | ||
| Q3 24 | — | $27.5M | ||
| Q2 24 | $49.6M | $32.4M | ||
| Q1 24 | — | $17.9M |
负债/权益比
SPCB
TLSI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.63× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.11× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-2.2M | $-2.5M |
| 自由现金流经营现金流 - 资本支出 | $-3.6M | $-2.5M |
| 自由现金流率自由现金流/营收 | -25.3% | -19.1% |
| 资本支出强度资本支出/营收 | 10.0% | 0.3% |
| 现金转化率经营现金流/净利润 | -0.41× | — |
| 过去12个月自由现金流最近4个季度 | $-14.0M | $-19.1M |
8季度趋势,按日历期对齐
经营现金流
SPCB
TLSI
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.7M | ||
| Q2 25 | $-2.2M | $-7.3M | ||
| Q1 25 | — | $-4.5M | ||
| Q4 24 | — | $-5.7M | ||
| Q3 24 | — | $-10.8M | ||
| Q2 24 | $-950.0K | $-13.4M | ||
| Q1 24 | — | $-10.9M |
自由现金流
SPCB
TLSI
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | $-3.6M | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | $-1.6M | $-13.5M | ||
| Q1 24 | — | $-10.9M |
自由现金流率
SPCB
TLSI
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | -25.3% | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | -10.8% | -183.1% | ||
| Q1 24 | — | -169.3% |
资本支出强度
SPCB
TLSI
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | 10.0% | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | 4.2% | 0.8% | ||
| Q1 24 | — | 1.0% |
现金转化率
SPCB
TLSI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.41× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.32× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图